1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDuchenne Muscular Dystrophy Research Program is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). The Duchenne Muscular Dystrophy Research Program is accepting applications for two award mechanisms, supporting research into Duchenne Muscular Dystrophy.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research FY26 Duchenne Muscular Dystrophy Research Program FY26 Duchenne Muscular Dystrophy Research Program (DMDRP) Synopsis of FY26 DMDRP Award Mechanisms - (Adobe PDF) - provides a brief description and key elements of the award mechanism.
Program Announcement/Instructions Clinical Translational Research Award Pre-Application (Letter Of Intent): September 4, 2026 5:00 p. m. Eastern Time (ET) September 18, 2026 11:59 p.
m. ET Pre-Application (Letter Of Intent): September 4, 2026 5:00 p. m.
Eastern Time (ET) September 18, 2026 11:59 p. m. ET For further information, please send e-mail to: CDMRP Webmaster - for download-related questions Help@ebrap.
org - for program announcement-related questions FY14 BCRP Recommended for Funding List
According to the current listing, eligibility includes: Research institutions, universities, and for-profit businesses are generally eligible, but specific eligibility depends on the individual CDMRP announcement. Confirm the full requirements in the official notice before applying.
Duchenne Muscular Dystrophy Research Program is funded by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Rare Cancers Research Program (RCRP) Concept Award is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). The FY26 RCRP Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation in rare cancers.
Pancreatic Cancer Research Program, Idea Development Award is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). This award mechanism supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements to accelerate progress in improving outcomes for individuals with pancreatic cancer.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article